Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce W S Robinson

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Hematology/Oncology Clinics of North America|December 6, 2005
Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related proteinJenette Creaney, Bruce W S Robinson
Thorax|December 7, 2014
Author's response: Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studiesJenette Creaney, Bruce W S Robinson
Chest|December 24, 2016
Malignant Mesothelioma Biomarkers: From Discovery to Use in Clinical Practice for Diagnosis, Monitoring, Screening, and TreatmentJenette Creaney, Bruce W S Robinson
Current Opinion in Pulmonary Medicine|May 7, 2009
Serum and pleural fluid biomarkers for mesotheliomaJenette Creaney, Bruce W S Robinson
Nature Reviews. Cancer|May 3, 2005
Immunotherapy and chemotherapy--a practical partnershipRichard A Lake, Bruce W S Robinson
The New England Journal of Medicine|October 14, 2005
Advances in malignant mesotheliomaBruce W S Robinson, Richard A Lake
The Medical Journal of Australia|December 14, 2004
Climbing Mount Kilimanjaro in a blizzardBruce W S Robinson, Mark G Edwards
Respirology (Carlton, Vic.)|December 31, 2021
Why we still need drugs for COVID-19 and can't just rely on vaccinesBruce W S Robinson, Anna Tai, Kyle Springer
Current Pulmonology Reports|May 1, 2015
Discovery of new biomarkers for malignant mesotheliomaJenette Creaney, Ian M Dick, Bruce W S Robinson
Frontiers in Pharmacology|April 18, 2022
How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New TherapiesBruce W S Robinson, Alec J Redwood, Jenette Creaney
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Hematology/Oncology Clinics of North America|December 6, 2005
Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related proteinJenette Creaney, Bruce W S Robinson
Thorax|December 7, 2014
Author's response: Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studiesJenette Creaney, Bruce W S Robinson
Chest|December 24, 2016
Malignant Mesothelioma Biomarkers: From Discovery to Use in Clinical Practice for Diagnosis, Monitoring, Screening, and TreatmentJenette Creaney, Bruce W S Robinson
Current Opinion in Pulmonary Medicine|May 7, 2009
Serum and pleural fluid biomarkers for mesotheliomaJenette Creaney, Bruce W S Robinson
Nature Reviews. Cancer|May 3, 2005
Immunotherapy and chemotherapy--a practical partnershipRichard A Lake, Bruce W S Robinson
The New England Journal of Medicine|October 14, 2005
Advances in malignant mesotheliomaBruce W S Robinson, Richard A Lake
The Medical Journal of Australia|December 14, 2004
Climbing Mount Kilimanjaro in a blizzardBruce W S Robinson, Mark G Edwards
Respirology (Carlton, Vic.)|December 31, 2021
Why we still need drugs for COVID-19 and can't just rely on vaccinesBruce W S Robinson, Anna Tai, Kyle Springer
Current Pulmonology Reports|May 1, 2015
Discovery of new biomarkers for malignant mesotheliomaJenette Creaney, Ian M Dick, Bruce W S Robinson
Frontiers in Pharmacology|April 18, 2022
How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New TherapiesBruce W S Robinson, Alec J Redwood, Jenette Creaney
Pageof 10